NCT07863856Phase 2/3Not yet recruiting
Efficacy of Botulinum Toxin A Versus Nanofat in the Treatment of Androgenetic Alopecia: A Comparative Clinical Trial
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Not yet recruiting
- Declared phase
- Phase 2/3
- Sponsor
- Sherief Ayman Hussein Shaamash
- Participants (registry)
- 40
- Start
- December 2026 (planned)
- Primary completion
- August 2028 (planned)
- Study completion
- October 2028 (planned)
- Last registry update
- October 2026
- Countries
- Egypt
Conditions studied: Androgenetic Alopecia
Interventions: Botulinum Toxin Type A, Autologous Nanofat Injection
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.